ROGELIO MADRUGA PAU: Open Payments
NPI 1417571019 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 52 payments from 7 companies in 2025. Trend: 2023 $2,067 · 2024 $2,597 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $587 |
| ABBVIE INC. | 17 | $568 |
| Alkermes, Inc. | 6 | $205 |
| Axsome Therapeutics, Inc. | 4 | $153 |
| Lundbeck LLC | 5 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
Products named: REXULTI, VRAYLAR, Auvelity, LYBALVI, CAPLYTA, ARISTADA, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
